Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1

Interventions

Gemcitabine 3 Pancreaticoduodenectomy 2 Oxaliplatin 2 Erlotinib Hydrochloride 2 olaparib 1 irinotecan sucrosofate 1 ferric carboxymaltose 1 binimetinib 1 Taxes 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation 1 Propranolol 1 Positron Emission Tomography Computed Tomography 1 Pancreatectomy 1 Nivolumab 1 Mitomycin 1 Leucovorin 1 Ipilimumab 1 Immobilization 1 Hyperthermic Intraperitoneal Chemotherapy 1 Fluorouracil 1 Etodolac 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Drainage 1 Curcumin 1 Congresses as Topic 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Pancreatic Neoplasms × Etodolac × Clear all

NCT03838029 2019-11-20

BC-PC

Assaf-Harofeh Medical Center

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡